Facts about the Alzheimer's disease... Jul 08
Today, Biogen and Eisai, Co., Ltd. announced that Biogen has submitted a Japanese New Drug Application (J-NDA) to the Ministry of Health, Labor and ... Dec 10
Public Citizen's Health Research Group said that the FDA should not approve aducanumab for treatment of Alzheimer's disease due to lack of evidence ... Nov 07
The FDA now has up to 60 days to decide whether to accept the application for review... Jul 09
-Advertisements-